Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

Teaser

One wood product from this company spends its working life buried in gravel, bearing the weight of freight trains. A nearly identical length of pressure-treated wood from the same operations spends its life standing upright, carrying power lines overhead instead. Both start as logs harvested across North America and pass through the same treatment process before they are sold under some of the longest-running supply arrangements in heavy industry.

The business manufactures and sells treated wood and steel infrastructure products to electrical utilities and to Class 1, short-line and commercial railroads under multi-year supply commitments, and separately distributes treated residential lumber through big-box and specialty retailers. It added two manufacturers to its utility business in a single recent year. Its shares currently trade more than 30% below their 52-week high, after a quarter in which net income fell by more than 40% from the year-earlier period, even as the company's own targets point toward annual sales well above where revenue sits today.

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

About Karooooo

Karooooo Ltd. (NASDAQ: KARO) is a Singapore-incorporated holding company operating mainly through its Cartrack subsidiary, a cloud-based Operational Intelligence Platform for vehicle and asset tracking.

Founded in 2001 and headquartered in Singapore, the group builds proprietary hardware and software spanning vehicle and asset tracking, field workforce management, workflow automation, and AI-powered video intelligence. A second unit, Karooooo Logistics, runs a delivery-as-a-service platform spanning owned-fleet, third-party-carrier and crowd-sourced delivery models. About 75% of FY2026 group revenue came from South Africa, where Cartrack competes against Tracker, Netstar and Power Fleet, and in Europe against Geotab, WebFleet and Masternaut. The business is closely identified with founder and CEO Isaias (Zak) Jose Calisto.

Unlock the full earnings deep dive by upgrading your subscription now!

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

Teaser

A company that builds instruments precise enough to find a single flawed splice in a fiber-optic network also makes the device a surgeon uses to measure the curve of a patient's eye before cataract surgery. Both products come from the same group of sixteen subsidiaries, bound together by one skill, bending and measuring light with extreme precision.

One division sells tunable lasers and scanning instruments to telecom equipment makers and semiconductor fabs, chasing the same capital spending wave lifting artificial-intelligence infrastructure worldwide. Another sells optical biometers, through a single dominant distribution partner, into clinics ahead of cataract procedures. A third, much smaller unit sells software that defends against ransomware. Net profit at the parent has grown at better than a 46 percent annual pace over the past four fiscal years. The shares, meanwhile, sit roughly 45% below the 52-week high they reached earlier this year, trading at a little under 25 times trailing earnings.

🇯🇵 santec Holdings Corporation (TSE: 6777)

Executive Summary

• AI-linked inflection in optical components: revenue in the optical components segment rose 41.2% YoY in FY2026 to ¥6.4 billion, driven by demand for optical monitors tied to AI and data-center infrastructure buildout.

• A measuring-instruments franchise that dominates the mix: tunable lasers, scanning instruments, OCT systems and ophthalmic biometers together supplied 71.0% of FY2026 revenue and grew 24.6% YoY.

• Profit growing faster than revenue: net profit rose 51.3% YoY in FY2026 to ¥7.7 billion, against 31.1% revenue growth, lifting the net margin to 24.3%.

• A net cash balance sheet: ¥16.3 billion in cash set against ¥2.8 billion in debt as of FY2026, with no stated near-term refinancing pressure.

• 24.92x trailing, 25.47x forward earnings: shares near ¥19,060 sit roughly 45% below their 52-week high of ¥34,700.

Business Overview

santec traces to Kyodo Shoji Corporation, established in August 1979 in Komaki, a city in Japan's Aichi prefecture. The company moved into optical communications in the early 1980s and took the Santec name in 1983, a shift that set the direction for everything the group has built since. In April 2023, the operating business reorganized under a new holding company, santec Holdings Corporation, which now oversees 16 subsidiaries spanning optical components and optical measuring instruments. The holding-company structure formalized decades of organic growth across what had been a looser group of operating companies, centralizing finance and reporting while leaving product development inside the specialist subsidiaries themselves.

The group's output splits into two broad families of products. One side builds components, power monitors, attenuators, filters and spatial light modulators, sold mainly to the makers of optical transmission equipment. The other builds measuring instruments, tunable lasers, high-speed scanning lasers, optical coherence tomography systems, and ophthalmic biometers sold under the ARGOS brand through eye-care distribution channels. A smaller systems-solutions unit sells communications software, including ransomware-countermeasure products.

What ties the group together is a single technical competence, generating, splitting, tuning and measuring light with extreme precision, applied across telecommunications test gear, semiconductor process tools and medical devices. That overlap of telecommunications-grade optical engineering, semiconductor-industry measurement tolerances and medical-device quality systems, all housed inside one 16-subsidiary group, is not something a competitor focused on only one of those three end markets can assemble quickly. Four decades of accumulated engineering inside a single corporate family, now organized under one holding structure, forms an asset a new entrant would need years to replicate even with comparable capital.

How the Company Makes Money

Three segments generate santec's revenue, and the FY2026 mix shows where the growth is concentrated. The optical measuring-instruments business, spanning communications test equipment, industrial and semiconductor tools, and the ARGOS ophthalmic biometer line, produced ¥22.4 billion, 71.0% of group revenue, up 24.6% YoY. Equipment makers, fabs and medical distributors buy these instruments through a mix of one-off capital purchases and recurring replacement cycles tied to new product qualification.

The optical components segment, power monitors, attenuators, filters and spatial light modulators sold mainly to optical transmission equipment manufacturers, contributed ¥6.4 billion, 20.2% of revenue, and was the fastest-growing of the three at 41.2% YoY. These are largely recurring, embedded sales, components designed into a customer's equipment tend to stay there through multiple product generations.

The remaining 8.8% of revenue, ¥2.8 billion, comes from a systems-solutions business selling software and communications systems, including ransomware-countermeasure products, and grew 77.0% YoY off a small base.

A single customer, Alcon, Inc., accounted for 17.7% of consolidated FY2026 net sales, down from 21.5% in FY2025, concentrated almost entirely in the ophthalmic biometer line. That relationship sits inside the measuring-instruments segment and helps explain why that segment, despite being by far the largest, grew more slowly this year than the smaller components business. The components segment's growth, tied to optical monitor demand for AI and data-center infrastructure, is currently the fastest-moving part of the group, even as the instruments segment remains the largest in absolute revenue.

Financial Performance

Revenue rose in each of the four years from FY2022 to FY2026, climbing from ¥8.9 billion to ¥31.5 billion, a compound annual growth rate of 37.2%. Net profit moved even further over the same stretch, from ¥1.6 billion to ¥7.7 billion, a 46.9% compound annual rate.

The climb was not a straight line. FY2023 alone saw revenue jump 71.5% and profit 82.2%, the steepest single year in the series, as a broader upswing in global optical-communications capital spending lifted demand across the measuring-instruments business and the then-smaller components lines together. Growth then settled into a lower but still rapid band, revenue up 23.8% in FY2024 and 27.3% in FY2025, before accelerating again to 31.1% in FY2026 as AI and data-center infrastructure spending pulled fresh demand specifically into the optical components segment. In every one of those four years, profit grew faster than revenue, culminating in FY2026's 51.3% profit increase against 31.1% revenue growth, the widest gap in the series. That gap traces mostly to the components segment's 41.2% growth and the small systems-solutions unit's 77.0% growth, both carrying higher incremental profitability than the larger, more mature instruments business, which itself still grew a respectable 24.6%.

FY2026 margins came in at 57.7% gross, 32.8% operating and 24.3% net. Net margin, computed from each year's reported revenue and profit, climbed in a straight line beforehand too, from roughly 18.5% in FY2022 to 19.7% in FY2023, 20.4% in FY2024, 21.1% in FY2025 and 24.3% in FY2026. Four consecutive years of margin improvement point to added volume dropping to the profit line at an increasing rate, rather than being absorbed by proportionally higher costs.

The most recent quarterly release, covering April through June 2026, left the FY2027 forecast unchanged when management reaffirmed it in early August. Secondary reporting pointed to continued revenue growth on strong North American demand for optical monitors and optical-communications test instruments, without breaking out the quarter's own figures. The next scheduled report will be read against FY2027 guidance of ¥37.0 billion in net sales, implying growth of about 17%, a deceleration from the 31.1% FY2026 delivered that management's own forecast already assumes.

Cash Flow and Balance Sheet

santec closed FY2026 with ¥16.3 billion in cash against ¥2.8 billion in debt, a net cash position of roughly ¥13.5 billion, cash running at more than five times the debt balance. That cash pile is more than twice FY2026 net profit of ¥7.7 billion, accumulated as profit growth has consistently outpaced the capital the business has needed to reinvest.

A debt load under ¥3 billion, against a group generating over ¥31 billion in annual revenue, leaves little balance-sheet risk from leverage. FY2027 guidance already builds in a dividend of ¥230 per share with no mention of new borrowing, a sign the group expects to keep funding itself from retained profit. Against FY2027 guidance of ¥8.8 billion in profit attributable to owners, that dividend forecast still leaves the bulk of forecast earnings retained inside the business.

The combination points to a company funding its own growth internally. Revenue has scaled from ¥8.9 billion to ¥31.5 billion since FY2022 without a matching rise in debt, and that retained profit, added to an already net-cash balance sheet, is the main internal funding source available for the capacity expansion that 17% guided sales growth would require.

Margins and Operating Leverage

FY2026 margins stood at 57.7% gross, 32.8% operating and 24.3% net. Net margin, calculated from each year's reported revenue and profit, rose in a straight line beforehand too, roughly 18.5% in FY2022, 19.7% in FY2023, 20.4% in FY2024, 21.1% in FY2025 and 24.3% in FY2026. Four consecutive years of improvement point to added revenue dropping to the profit line at a rising rate, not absorbed by proportionally higher costs.

Between the 57.7% gross margin and the 32.8% operating margin sits a 24.9 percentage point gap, spent mostly on R&D, sales and administrative costs that support all three segments at once. Operating margin converts to a 24.3% net margin after tax and other items, an 8.5 percentage point step down. Both gaps matter for how much of incremental revenue growth converts into profit versus simply covering overhead that itself scales with a growing, more complex three-segment business.

The mechanism specific to santec is a manufacturing and R&D base built around specialized optical engineering, a cost structure that does not need to grow in step with every additional unit sold once a product line is qualified with a customer. The components segment illustrates this most sharply, its 41.2% FY2026 revenue growth, tied to optical monitor demand from AI and data-center infrastructure spending, arrived on top of existing production lines and existing customer qualifications, work already paid for in prior years.

What would reverse the pattern is visible in the risk list below. A slowdown in optical-communications capital spending, which the company itself describes as prone to sharp swings, would cut volume through the same fixed base in the other direction, compressing margins as quickly as they expanded. Selling-price erosion from competitive bidding, a dynamic the company has flagged in its own disclosures, attacks the same margin mechanism from the pricing side.

Capital Allocation

santec's FY2027 guidance carries a dividend forecast of ¥230 per share, against a share price near ¥19,060 and a trailing dividend yield of 1.21%. That modest payout, set beside ¥16.3 billion in cash and only ¥2.8 billion in debt, suggests a board still prioritizing reinvestment and balance-sheet strength over returning cash to shareholders.

The clearest signal of where capital is going is the revenue mix itself. The fastest-growing segments are getting the most reinvestment attention, components up 41.2% in FY2026 on AI and data-center infrastructure demand, and systems-solutions up 77.0% off a small base. Running 16 subsidiaries under one holding structure since April 2023 is itself a form of capital allocation, centralizing finance, reporting and other shared functions across what had been a more fragmented set of operating companies.

No acquisitions or buyback programs are described. The group's roughly ¥13.5 billion net cash position, built up through several years of profit outpacing revenue growth, gives it room to fund further capacity in optical components or additional R&D in measuring instruments without needing external financing, should management choose to use it that way.

Growth Outlook

Management's own forecast for FY2027, ending March 2027, set in mid-May 2026 and left unchanged when the company reported first-quarter results in early August, calls for net sales of ¥37.0 billion, operating profit of ¥12.0 billion, ordinary profit of ¥12.1 billion, and profit attributable to owners of ¥8.8 billion. The forecast also carries an annual dividend of ¥230 per share, which would mark a continued increase if realized. Measured against FY2026's actual ¥31.5 billion in revenue, the guidance implies growth of about 17%, a deceleration from the 31.1% FY2026 delivered, though management reaffirmed the number rather than cutting it when it had the chance to in August.

Four developments could move results against that guidance. AI and data-center infrastructure spending is the most direct lever, optical monitor demand drove the components segment's 41.2% FY2026 growth, and continued buildout could extend that pattern, though the pace of AI-related capital spending is itself uncertain and could slow.

Semiconductor-industry demand for optical measuring instruments is a second lever, tied to fab investment cycles that move independently of the telecom cycle and could broaden the customer base for test equipment beyond communications-equipment makers.

The ophthalmic biometer line depends heavily on one distribution relationship that represented 17.7% of FY2026 sales, down from 21.5% the year before. Whether that share stabilizes, keeps shrinking as other channels grow, or reverses is likely to show up directly in the measuring-instruments segment's reported growth rate.

The systems-solutions business, still only 8.8% of revenue but up 77.0% in FY2026, could continue scaling demand for ransomware-countermeasure software, though its small base means it may not move group-level results much even if it keeps growing quickly.

Valuation Analysis

As of October 20, 2026, santec Holdings Corporation shares trade at approximately ¥19,060, giving the group a market value near ¥228.0 billion. That places the stock at 24.92x trailing earnings and 25.47x forward earnings, multiples close enough together that the market appears to expect earnings growth over the coming year similar in magnitude to the past year's pace.

The shares carry a 1.21% dividend yield at the current price, against the ¥230 per-share dividend management has forecast for FY2027. Over the past 52 weeks, the stock has ranged from ¥7,390 to ¥34,700, meaning the current ¥19,060 sits roughly 45% below its yearly high and more than double its yearly low.

Set beside those multiples, the business grew revenue at a 37.2% compound annual rate and net profit at a 46.9% compound annual rate between FY2022 and FY2026, with the FY2026 net margin, 24.3%, the highest point in that five-year series. The width of the gap between the 52-week high and the current price stands out against a FY2026 in which profit growth actually accelerated to 51.3% YoY, pointing to share-price movement driven by factors beyond the reported growth rate itself. The small gap between the trailing and forward multiples, under one full turn, leaves little room in the current price for a meaningful acceleration or slowdown in earnings beyond what management's own FY2027 guidance already implies. No enterprise-value or EV/EBITDA figures were available to set against the group's net cash position.

Competitive Landscape and Risks

santec does not name competitors directly in its own disclosures, but industry and secondary sourcing place several public companies in adjacent corners of its three markets. VIAVI Solutions Inc. (NASDAQ: VIAV) and Lumentum Holdings Inc. (NASDAQ: LITE) both operate in optical network test and component markets overlapping with santec's measuring-instruments and components businesses. Yokogawa Electric Corporation (TSE: 6841) also produces optical measuring instruments. EXFO Inc., once a direct competitor in fiber-optic test equipment, was taken private and delisted from NASDAQ and the TSX in August 2021, removing one more public comparison point from the space. santec's own disclosures describe its competitors more broadly as larger optical-subsystem, module and component makers, and the in-house optical divisions of major communications equipment vendors, several of which carry greater financial, technical and sales resources than santec itself.

The key risks investors should monitor include:

1. Customer Concentration. Alcon, Inc. alone accounted for 17.7% of consolidated FY2026 net sales, down from 21.5% the year before, concentrated almost entirely in the ophthalmic biometer line. A reduction in orders from Alcon, or from any other major customer, would affect results more than a comparable loss would at a less concentrated supplier.

1. Optical-Communications Industry Cyclicality. santec describes a majority of its revenue as tied to capital spending by optical-communications carriers and equipment makers, a category the company itself calls subject to sharp and hard-to-predict swings. A downturn in that spending, whether from a slowdown in AI-related infrastructure investment or a broader capex pullback, could also force inventory write-downs on products built for demand that does not materialize.

1. Competitive Pressure. Larger optical-subsystem and component makers, along with in-house optical divisions at major communications equipment vendors, compete for the same customers with greater financial, technical and sales resources than santec can deploy on its own. Competitive bidding and new product introductions from these rivals have put some of santec's own products on a declining price trend, a dynamic the company has flagged in its own filings.

1. Key-Person Dependency. santec cites reliance on Representative Director and President Jeong Won-ho and certain other executives and employees who hold external relationships and specialized expertise the company says would be difficult to replace.

1. Currency and Overseas Operations. Overseas sales are transacted mainly in US dollars, with additional exposure to the British pound, the euro and the Chinese yuan, while manufacturing takes place in Vietnam. That combination exposes reported results to currency swings on top of the foreign political, regulatory and labor risk that comes with operating a manufacturing base outside Japan.

Each of these risks interacts with the others. A slowdown in carrier capex would hit both the cyclicality and competitive-pricing risks at once, since weaker demand typically sharpens price competition for the orders that remain.

Summary

santec Holdings sits at the intersection of two very different end markets, both growing for reasons that have little to do with each other. One division is riding the same AI and data-center infrastructure spending wave lifting optical-component demand across the industry, posting 41.2% segment growth in FY2026. The other builds precision measuring instruments for telecom, semiconductor and ophthalmic customers, a business large enough to supply 71.0% of group revenue even while growing more slowly than the smaller components unit.

The five-year numbers are not in dispute. Revenue compounded at 37.2% annually from FY2022 to FY2026, and net profit compounded faster still, at 46.9%, with the net margin climbing in every one of those years to reach 24.3%. A ¥16.3 billion cash position against ¥2.8 billion in debt gives the group room to keep funding its own growth.

What is less settled is customer concentration tied to one ophthalmic distribution relationship, now 17.7% of sales and shrinking, and a core optical-communications cycle the company itself describes as prone to sharp reversals. The stock trades roughly 45% below its 52-week high even as FY2026 profit growth accelerated to 51.3%, a gap between the reported numbers and the share price that has not closed.

The same optical engineering that keeps a data center's fiber lit now also keeps a surgeon's view of the human eye in precise focus, and both applications of that one skill are still compounding at a pace most industrial suppliers never reach.

Important disclaimer:

Data is taken from Fiscal.ai and company website.

The content provided in this newsletter is for informational purposes only and should not be construed as financial or investment advice. While I strive for accuracy, some metrics and data presented in these reports may not be entirely accurate or up-to-date. I take no responsibility for any investment decisions made based on the information provided herein.

Investing in the stock market, especially in undiscovered or lesser-known companies, carries inherent risks. The companies discussed in this newsletter may be subject to volatility, liquidity issues, and other factors that could impact their performance.

It is crucial that you conduct your own thorough research and due diligence before making any investment decisions. I strongly recommend consulting with a qualified financial advisor who can provide personalized advice based on your individual financial situation, risk tolerance, and investment goals.

Remember that past performance is not indicative of future results. The stock market is subject to fluctuations, and the value of investments may go up or down. You should only invest money that you can afford to lose.

By subscribing to and reading this newsletter, you acknowledge that you understand and accept these risks and limitations. You agree that I will not be held liable for any losses or damages resulting from the use of information provided in this newsletter.

Always invest responsibly and within your means. Your financial decisions are ultimately your own responsibility.

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

Teaser

Inside a clean room outside Seoul, a cantilever probe thinner than a strand of hair drags across a silicon wafer, tracing surface features only a few atoms tall. The instrument reading that surface costs as much as a house and ships into some of the most advanced chip fabs on the planet, installed next to equipment stamped with far more recognizable brand names.

The company that builds it holds the largest share of a niche measurement market most investors have never priced, ahead of a NASDAQ-listed rival close to its own size and a London-listed one not far behind. Its revenue has climbed every year since 2021. Its profit fell 19.5% last year, and fell again sharply in the first half of this one. Its stock trades at roughly 78 times trailing earnings, in the lower half of its 52-week range.

Read more

Looking for more detailed research analyses of undiscovered companies around the world, top monthly discoveries, and a list of 100+ undiscovered stock from around the globe? Become a Paid Subscriber and get many more benefits!

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

In the first half of 2026, a company that had carried no bank debt in years quietly drew down two short-term credit lines worth €65 million. A few months earlier, it had just closed its first full year above a billion euros in revenue, with profit up nearly a third.

The business sells hardware that most people only ever encounter in a hotel basement or a corporate gym, bundled with an app and a library of training content that keeps the relationship going long after the equipment ships. Revenue has compounded for four straight years. The stock, meanwhile, sits well off its yearly high, and the company just borrowed money for the first time in a long while. That combination, growth up, leverage appearing, shares down, is where this one gets interesting.

🇮🇹 Technogym S.p.A. (Euronext Milan: TGYM)

Executive Summary

• Crossing the billion-euro mark: FY2025 revenue reached €1,019.3 million (+13.1% YoY), the first time the company has closed a year above a billion euros, while adjusted net profit climbed to €119.9 million (+32.9% YoY).

• Two channels, one ecosystem: The business splits 80.8% BtoB (gyms, hotels, corporate and healthcare wellness) and 19.2% BtoC (home consumers), with BtoB growing +14.9% YoY and BtoC +6.2% YoY inside a single connected-hardware-plus-content model.

• Margins under near-term pressure: H1 2026 adjusted EBITDA margin compressed to 17.4% from 18.5% a year earlier, as freight and raw-material costs, tied partly to AI-driven demand for electronic components, outpaced volume gains.

• A balance sheet that just changed character: Having carried no bank debt at the close of FY2025, the company drew €65 million on two revolving credit facilities in H1 2026, as net financial position fell to €88.6 million from €156.0 million.

• Valuation reflects consensus optimism: Shares trade at 22.1x trailing earnings and 11.9x EV/EBITDA, with analyst consensus pointing to roughly 38% upside to the average 12-month analyst price target.

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Business Overview

Technogym was founded in Italy in 1983 and has grown into a global designer and manufacturer of connected fitness, sport and wellness equipment. The company sells smart hardware bundled with a companion app and on-demand training content, so the relationship with a customer continues well past the point of sale. That ecosystem approach, hardware as the entry point and software as the retention mechanism, is the core of the business model.

The group serves two distinct customer bases. Its BtoB arm sells to gyms, hotels, corporate wellness programs and healthcare operators, while its BtoC arm sells directly to individual consumers for home use. Reinforcing the brand, Technogym has been the official equipment supplier to the last ten Olympic and Paralympic Games, a run that now includes Milano Cortina 2026. That kind of sustained visibility at the highest level of global sport is difficult for a competitor to replicate on a marketing budget alone, and it feeds directly into the premium positioning the company carries in both its channels.

How the Company Makes Money

Technogym's revenue is built almost entirely on two channels. The BtoB segment, selling to gyms, hotels, corporate and healthcare wellness centers, generated €823.6 million in FY2025 (+14.9% YoY) and accounted for 80.8% of total revenue. The BtoC segment, selling to individual home users, generated €195.7 million (+6.2% YoY) and made up the remaining 19.2%.

Both channels monetize the same underlying product architecture: connected cardio, strength and wellness equipment, supplemented by digital app and content revenue that sits inside Technogym's own ecosystem rather than a third-party platform. Distribution runs through four parallel paths. Field sales and wholesale cover large commercial accounts and dealer networks, inside sales covers telesales and e-commerce, and a network of retail boutiques gives the consumer business a physical showroom presence. The mix matters because BtoB is growing more than twice as fast as BtoC in percentage terms, even though BtoC is the smaller base, which suggests the commercial channel is currently doing more of the heavy lifting on growth.

Financial Performance

Revenue has climbed every year for the last four fiscal years. FY2021 revenue was €611 million. FY2022 revenue rose to €721 million (+18.0% YoY). FY2023 revenue reached €808 million (+12.1% YoY). FY2024 revenue came in at €901.3 million (+11.5% YoY). FY2025 revenue reached €1,019.3 million (+13.1% YoY), the first time the company has topped a billion euros in a single year.

Adjusted net profit has grown even faster than revenue, a sign of operating leverage building through the period. FY2021 adjusted net profit was €63 million. FY2022 came in at €64 million (+1.6% YoY), essentially flat. FY2023 jumped to €74 million (+15.6% YoY). FY2024 rose to €90.2 million (+21.9% YoY). FY2025 reached €119.9 million (+32.9% YoY), with adjusted net margin expanding to 11.8% of revenue. For reference, IFRS net profit attributable to owners of the parent for FY2025 was €115.1 million, close to but not identical to the adjusted figure the company features in its own highlights.

The most recent half tells a more complicated story. H1 2026 revenue reached €492.6 million, up 7.4% YoY on a reported basis and up 9% YoY at constant exchange rates, meaning currency movement cost the company roughly 1.6 percentage points of headline growth. IFRS net profit attributable to owners for H1 2026 was €42.3 million, while the company's own adjusted net income metric came in at €43.8 million, up just 0.3% YoY. That near-flat adjusted profit growth, against still-positive revenue growth, is the first real crack in an otherwise clean run and is explored further below.

Cash Flow and Balance Sheet

Technogym ended FY2025 with €207.8 million in cash and €57.7 million in financial liabilities, including IFRS 16 lease obligations, both current and non-current. The company states it carried no bank debt at all as of 31 December 2025, a position management has evidently prioritized for some time.

That changed during H1 2026. The company drew €65 million across two short-term revolving credit facilities, its first bank borrowing in years. Net financial position fell from a positive €156.0 million at the end of FY2025 to a positive €88.6 million at the end of H1 2026, after dividend payments and net investment outflows. Recurring cash conversion, the share of earnings that actually turns into cash, dropped to 47% in H1 2026 from 86% in H1 2025, as higher freight and raw-material costs ate into the cash generated from the income statement. The combination of a smaller net cash cushion and a weaker conversion rate is worth watching into the back half of the year, even though the company remains in a net cash position overall.

Margins and Operating Leverage

Technogym's adjusted EBITDA margin climbed steadily from 17.5% in FY2021 to 18.3% in FY2022, 18.8% in FY2023 and 19.8% in FY2024, a three-year run of expansion that matches the acceleration in adjusted net profit over the same period. For FY2025, the company's headline profitability metrics shift slightly in presentation, with adjusted ROS (return on sales) at 16.1% and adjusted net margin at 11.8%.

The operating-leverage mechanism behind that earlier expansion is fairly intuitive. Technogym carries a largely fixed manufacturing, R&D and sales infrastructure, so incremental revenue from a growing installed base and a growing app and content library tends to flow through to profit at a higher rate than revenue itself grows, a flywheel that rewards scale. H1 2026 shows what happens when that mechanism runs in reverse. Adjusted EBITDA margin fell to 17.4% from 18.5% in H1 2025 (-1.1 percentage points YoY), as higher freight and raw-material costs outpaced volume gains. Whether that reverses depends largely on whether the cost pressures described below prove temporary.

Capital Allocation

Management has guided total capital investment for 2026 at approximately €80 million, directed at three priorities, expanding production capacity including a facility in Slovakia, building out a new Healthness Lab, and funding digital and AI initiatives. That is a meaningful capital commitment relative to a company with €207.8 million of cash on hand at the start of the year, and it helps explain why the company also reached for its first bank credit lines in years rather than funding everything from the balance sheet alone.

On the shareholder-return side, Technogym currently carries a dividend yield of 2.92%. A stated payout ratio or buyback program was not available for this piece, so neither is discussed here. The broader capital allocation picture, heavy reinvestment in capacity and digital capability alongside a modest cash dividend, points to a management team still prioritizing growth investment over capital return at this stage.

Growth Outlook

Technogym did not disclose a numeric revenue or profit target for FY2026. Instead, management states it "looks forward with confidence to the evolution of the current financial year," pointing to three qualitative supports, a positive trend in the order backlog, the stated uniqueness of its business model and brand positioning, and a net financial position that, while reduced, remains positive.

Four catalysts, all attributed to management guidance, stand out. The order backlog trend is described as positive, which if sustained would support revenue visibility into coming quarters, though management has not quantified the backlog itself. The Slovakia production expansion is intended to add manufacturing capacity, which could support unit growth if demand continues to track recent trends. The new Healthness Lab, part of the ~€80 million 2026 capex plan, is positioned as a site for product and wellness-concept development, though management has not detailed its expected contribution. Digital and AI initiatives, also funded from that same capex pool, are aimed at deepening the app and content side of the ecosystem, the part of the business that keeps customers engaged between hardware purchases.

Separately, management raised its price list in July 2026 in response to rising input costs, a move that could help offset the margin pressure seen in H1 2026 if it holds through the back half of the year without denting volume.

Valuation Analysis

As of 2026-10-06, Technogym shares trade at approximately €13.01, for a market capitalization of roughly €2.57 billion and an enterprise value of about €2.49 billion. The stock trades at 22.1x trailing earnings and 19.79x forward earnings, suggesting the market expects earnings growth ahead. On an enterprise basis, it trades at 11.9x EV/EBITDA and 2.36x EV/Revenue. The dividend yield sits at 2.92%. Shares currently sit well below the €21.82 high of their 52-week range and above the €11.92 low, closer to the bottom third of that band.

Ten analysts cover the stock with a consensus rating of Buy, carrying an average 12-month analyst price target of €17.99 (range €15.00–€24.50), which implies approximately 38% upside from the share price referenced in that same dataset, dated 2026-08-05. Set against a business that just posted its first billion-euro revenue year and 32.9% adjusted profit growth, the stock trades at 22.1x trailing earnings, 19.79x forward earnings and 11.9x EV/EBITDA, with the H1 2026 margin compression and the new bank borrowing factored into how the market has priced those multiples heading into the back half of the year.

Competitive Landscape and Risks

Technogym competes against a small set of large, well-capitalized rivals. Life Fitness, privately held under KPS Capital Partners, is the largest commercial gym-equipment supplier by installed base in major U.S. chains. Peloton Interactive (NASDAQ: PTON) owns Precor, a commercial equipment maker it acquired in 2020, giving Peloton a presence in both home and commercial fitness that overlaps with Technogym's BtoC and BtoB segments respectively. Johnson Health Tech (TWSE: 9941), based in Taiwan, competes globally across commercial and consumer equipment through its Matrix, Vision and Horizon brands. Core Health & Fitness, also privately held, competes in the mid-market with its Nautilus, Schwinn, StairMaster and Star Trac brands and its Wexer digital platform. The global commercial fitness-equipment market has consolidated around this small group of large players, which intensifies competition for the gym-chain and hospitality contracts that make up the bulk of Technogym's BtoB revenue.

Key risks investors should consider:

1. Bank debt drawn for the first time in years. Having carried no bank debt at 31 December 2025, the company drew €65 million on two short-term revolving credit facilities during H1 2026, as net financial position fell from €156.0 million to €88.6 million.

1. Margin and cash-conversion compression. H1 2026 adjusted EBITDA margin fell to 17.4% from 18.5% in H1 2025, and recurring cash conversion dropped to 47% from 86%, as higher freight and raw-material costs outpaced volume gains.

1. Geopolitical disruption to shipments. Management's H1 2026 results cite international shipment delays linked to an ongoing conflict, which pushed deliveries past scheduled dates and weighed on second-quarter revenue, with management flagging continued geopolitical uncertainty as a risk to the FY2026 outlook.

1. Input-cost inflation tied to the AI and data-center buildout. Management states that the broader AI boom and data-center construction wave have driven a sharp rise in electronic component costs, while higher energy costs have pushed up transportation and raw-material prices, pressuring product margins and prompting the July 2026 price increase.

1. Foreign-exchange exposure. H1 2026 revenue growth was reported at +7.4% versus +9% at constant exchange rates, meaning unfavorable currency movement reduced the headline growth rate, and currency fluctuation remains among the risk factors the company itself flags looking ahead.

Summary

Technogym's five-year arc is clean on paper, revenue compounding from €611 million to above a billion euros, adjusted profit nearly doubling, and margins expanding for three straight years before this year's wobble. The brand carries real weight, reinforced by a decade of Olympic and Paralympic equipment contracts, and the BtoB and BtoC channels both grew in FY2025 even if at different speeds.

What complicates the picture is entirely contained in H1 2026. Margins compressed, cash conversion dropped sharply, currency worked against reported growth, and a company that had avoided bank debt for years borrowed €65 million across two facilities, all while still guiding to roughly €80 million of 2026 capital investment. None of that erases the prior years of expansion, but it does mean the next few quarters will say more about the durability of this business than the last five did. The billion-euro year happened. Whether the stock eventually notices is the open question the shares, sitting well below their yearly high, have not yet answered.

Important disclaimer:

Data is taken from Fiscal.ai and company website.

The content provided in this newsletter is for informational purposes only and should not be construed as financial or investment advice. While I strive for accuracy, some metrics and data presented in these reports may not be entirely accurate or up-to-date. I take no responsibility for any investment decisions made based on the information provided herein.

Investing in the stock market, especially in undiscovered or lesser-known companies, carries inherent risks. The companies discussed in this newsletter may be subject to volatility, liquidity issues, and other factors that could impact their performance.

It is crucial that you conduct your own thorough research and due diligence before making any investment decisions. I strongly recommend consulting with a qualified financial advisor who can provide personalized advice based on your individual financial situation, risk tolerance, and investment goals.

Remember that past performance is not indicative of future results. The stock market is subject to fluctuations, and the value of investments may go up or down. You should only invest money that you can afford to lose.

By subscribing to and reading this newsletter, you acknowledge that you understand and accept these risks and limitations. You agree that I will not be held liable for any losses or damages resulting from the use of information provided in this newsletter.

Always invest responsibly and within your means. Your financial decisions are ultimately your own responsibility.

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

🇦🇹 AUSTRIA — Frequentis

Frequentis builds communication and control-room systems for air traffic control and public safety agencies, serving customers in around 150 countries.

Valued at about $895M, Frequentis trades at a forward 27x P/E, 10.7x EV/EBITDA and 1.15x EV/revenue for 2026e, down from 34.3x P/E and 13.1x EV/EBITDA in 2025. Management guides to roughly 15% revenue growth and a 7% EBIT margin for 2026, after H1 revenue jumped 44.8% on project milestones pulled forward from H2, a shift it calls temporary.

Frequentis AG $FQT $FQT.VI

🇲🇾 MALAYSIA — Frontken Corporation

Frontken cleans and refurbishes precision chamber parts for semiconductor foundries, mainly through its Taiwan subsidiary, plus maintenance work for oil and gas plants.

Valued at about $9.4B, Frontken trades at a trailing 48x P/E, forward 42x P/E, 30x EV/EBITDA and 11.5x EV/revenue, with a 25% net margin. Revenue grew around 7% and profit around 13% in FY2025, with roughly 70% of sales tied to leading-edge semiconductor nodes at Taiwan foundries.

Frontken Corporation Berhad $FRONTKN $FRONTKN.KL

🇫🇮 FINLAND — Revenio Group

Revenio makes eye-care diagnostic devices like glaucoma-screening tonometers, and after acquiring Visionix now sells refraction and lens equipment too.

Valued at about $303M, Revenio trades at a trailing 21.1x P/E, forward 11.9x P/E, 24.7x EV/EBITDA and 4.4x EV/revenue, with a 70.9% gross margin. Quarterly revenue jumped 48.1% after the Visionix acquisition closed in May 2026, though net profit fell as integration costs and new acquisition debt weighed on the quarter.

Revenio Group Oyj $REG1V $REG1V.HE

🇫🇮 FINLAND — Harvia

Harvia makes sauna heaters, saunas and steam and spa products, sold through retailers and wholesalers across Europe, North America and Asia-Pacific.

Valued at about $795M, Harvia trades at a forward 23.9x P/E and 3.7x EV/revenue, with a 19.3% operating margin and 13.3% net margin. Revenue grew about 13.5% in FY2025, and management's long-term targets call for roughly 10% annual growth with margins above 20%.

Harvia Oyj $HARVIA $HARVIA.HE

🔥 Looking for detailed research analyses of undiscovered companies around the world, top monthly discoveries, and a list of 100+ undiscovered stocks from around the globe? Become a Paid Subscriber and get many more benefits!

Disclaimer: This analysis is provided for informational and educational purposes and should not be construed as financial advice or a recommendation to buy or sell any security. The data and information presented have been obtained from sources believed to be reliable, but their accuracy and completeness cannot be guaranteed. Any investment decision should be made based on your own research, risk tolerance and financial situation. Stock markets and investments carry significant risks, possible loss of principal, and past performance does not guarantee future results. The author may hold positions in the securities discussed. The opinions expressed here reflect our best analysis at this point in time, but views and circumstances change rapidly. Always conduct thorough due diligence and consult with a qualified financial advisor before making any investment decisions. The analysis presented here may become outdated quickly due to the dynamic nature of markets and businesses. You are responsible for your own investment decisions, and should understand the risks of any investment before committing capital.

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

In the fall of 2015, a Dallas investment firm spun off its industrial holdings into a standalone public company. Nobody noticed. There was no product launch, no new technology, no story for the business press to chase. The new company simply kept doing what its pieces had always done, selling pipe sealant to plumbers, specialty lubricant to mining operators, and fire doors to architects who had never heard of it.

A decade later, that quiet collection of brands has become something closer to a diversified industrial holding company, three separate businesses stitched together through acquisition, each one a minor monopoly in a product category too small for larger competitors to bother with. Revenue just grew faster than it has in years. Profit, in the same year, fell by nearly a fifth. The market shrugged and kept paying more than forty times trailing earnings for the shares anyway.

Read more

Rea…

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

In 1917, in a modest workshop, three men began winding copper wire around steel cores, building transformers that step electricity up and down so it can travel from a generating station to a factory floor without burning out anything in between. Nobody remembers their names now. The machines they built do not carry a brand people recognize, are never photographed, and rarely appear in an annual report anyone outside industrial supply chains reads.

More than a century later, the same basic device sits behind almost anything that plugs into serious power: a hospital wing, an assembly line, a data center packed with racks of processors converting one form of electricity into another around the clock. Demand from that last category has become so intense that the company behind these unglamorous metal boxes closed 2025 with an order backlog up 122% year over year. Its shares, meanwhile, trade at more than fifty times trailing earnings, a multiple usually reserved for software, not sheet steel and copper wire. That gap between what the business sells and what the market pays for it is where this gets interesting.

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

Two device makers whose names you almost certainly know together account for nearly half the sales of a company you almost certainly do not. Neither name appears on the label. Their products move through operating rooms, catheter labs and diagnostic suites wrapped, cushioned, sealed or shaped by a supplier that never signs its own work.

That supplier has been at this since 1963, quietly moving from foam padding into single-use, single-patient medical components that get thrown away after one surgery and never thought about again. Its factories do not make a product you would recognize on a shelf. They make the parts that let other companies' products work, ship safely and pass sterility inspection. Revenue has nearly tripled since 2021. Profit has grown even faster. And the stock, after a run most investors never noticed, now trades at a multiple that assumes the growth keeps compounding for years to come. The question is whether a business built on staying unseen can keep justifying a price built on being seen clearly.

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

In September 2026, shares in a quietly assembled collection of scientific-instrument makers trade closer to a 52-week low than a 52-week high, even after the group just reported record revenue. Twenty-five businesses sit inside the structure, most of them making equipment that only a handful of labs anywhere in the world would recognize: vacuum chambers for materials research, oceanographic coring rigs, cryostats that keep experiments cold enough to observe quantum effects. None of it is sold to a consumer.

The company has spent more than two decades buying up niche instrument makers one at a time, paying management teams to stay on and keep running their own shops. Revenue climbed in four of the last five years to a record in 2025. Profit did not follow. A goodwill impairment, a research-funding freeze across the Atlantic and a UK tax burden cut statutory profit by nearly half even as the top line hit an all-time high. The trailing P/E has ballooned past 46 times earnings. The forward multiple, built on management's own guidance, sits under 19.

🇬🇧 Judges Scientific plc (AIM: JDG)

Executive Summary

• Two-decade compounding story, interrupted: revenue reached £145.8 million in FY2025 (+9.1% YoY), a record, while statutory profit fell to £6.0 million from £10.8 million the year before.

• A collector of niche monopolies: the group now comprises 25 trading businesses split almost evenly between Materials Sciences (£71.9 million, 49.3% of revenue) and Vacuum (£73.9 million, 50.7%).

• Natural exporter, natural hedge, natural risk: roughly half of revenue is priced in US Dollars and about a third in Euros against a Sterling cost base, so currency swings cut both ways.

• Guidance bakes in the worst case: management's 2026 Adjusted EPS guidance of 200p–250p assumes no Geotek coring expedition until early 2027 and no recovery in US trading.

• Cheap on one number, expensive on another: shares trade at 46.6x trailing earnings but 18.9x forward earnings, alongside a 3.01% dividend yield.

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Business Overview

Judges Scientific plc floated on London's AIM market in 2003 as a holding company built to acquire and develop niche manufacturers of scientific instruments. Rather than build new products from scratch, the strategy has consistently been to buy established, profitable businesses run by scientists and engineers who already know their customers, then leave them largely alone to keep running with light-touch oversight from the center.

Two decades of bolt-on acquisitions later, the group comprised 25 trading businesses at 31 December 2025, organized into two reporting segments: Materials Sciences and Vacuum. Both segments sell into the same broad pool of university, government and industrial research customers, but through different technologies. Vacuum-segment businesses, among them Oxford Cryosystems and UHV Design, build equipment for experiments that require extreme cold or extreme emptiness. Materials Sciences spans a wider mix of instrumentation and includes Geotek, a coring and geotechnical business whose expedition-driven revenue can swing sharply from one year to the next depending on whether a major research vessel happens to be at sea.

The group presents itself as a permanent owner rather than a portfolio manager hunting for an exit, a distinction that appears to matter to the founder-operators who sell into the structure and often stay on to run what they built. That continuity, more than any single product line, is the asset being assembled over time.

How the Company Makes Money

In FY2025, the Vacuum segment generated £73.9 million of the group's £145.8 million in total revenue, or 50.7%. Materials Sciences contributed £71.9 million, or 49.3%. The split is close enough that no single segment dominates group outcomes on its own, though Materials Sciences' Geotek business injects more year-to-year variability than the rest of the group combined. A coring expedition can add millions of pounds of revenue and profit within a matter of months, and its absence can subtract just as much the following year.

Across both segments, revenue comes mainly from one-off sales of instruments, spare parts and installation services, supplemented by service, maintenance and extended-warranty contracts that recur year to year. Growth is pursued through two channels: organic expansion inside the existing subsidiaries as they win new lab budgets and extend product lines, and disciplined bolt-on acquisitions of profitable niche instrument makers, funded from operating cash flow and a multi-bank revolving credit facility rather than repeated equity raises.

The customer base is overwhelmingly research-driven, spanning universities, national laboratories and industrial R&D departments across dozens of countries. That mix means order flow tracks global research budgets and the pace of scientific funding cycles, rather than any single national economic cycle.

Financial Performance

Revenue has grown in four of the last five years. FY2021 revenue was £91.3 million. FY2022 revenue rose to £113.2 million (+24.0% YoY). FY2023 revenue reached £136.1 million (+20.2% YoY). FY2024 revenue slipped to £133.6 million (-1.8% YoY), the only down year in the stretch. FY2025 revenue recovered to a record £145.8 million (+9.1% YoY).

Profit has moved in the opposite direction more often than not. FY2021 profit was £12.9 million. FY2022 profit held roughly flat at £12.8 million (-0.8% YoY). FY2023 profit fell to £9.9 million (-22.7% YoY). FY2024 profit recovered to £10.8 million (+9.1% YoY). FY2025 profit then fell sharply to £6.0 million (-44.4% YoY), even as revenue set a record, a gap driven by a goodwill impairment and other charges below the operating line rather than a collapse in underlying trading volumes.

The most recent half-year offers a cleaner read on operating momentum. In H1 FY2025 (six months ended 30 June 2025), revenue rose to £70.2 million (+15.5% YoY), helped by a Geotek coring expedition in Japan. Statutory profit for the period was £5.1 million, up from £4.3 million in H1 2024. Adjusted basic EPS rose 14.3% to 141.4p. Results for H1 FY2026 had not yet been published as of this writing, with a shareholder webinar covering the six months to 30 June 2026 scheduled for 23 September 2026.

Cash Flow and Balance Sheet

At 31 December 2025, the group held £19.4 million of cash against £59.6 million of gross borrowings, putting net debt at roughly £40.2 million. That leverage sits under a business that has historically converted a meaningful share of profit into cash, funding both the acquisition program and a progressive dividend without repeated trips to shareholders for fresh equity. The revolving credit facility that underpins the acquisition strategy gives the group flexibility to move on a deal without raising cash beforehand, though the debt load also leaves results more exposed to the cost of borrowing than a business funded entirely from its own balance sheet.

Margins and Operating Leverage

Operating margin stood at 19.2% in FY2025, against a net margin of 4.1%, a wide gap that reflects the distance between operating performance and the goodwill impairment and finance costs sitting below the operating line. Net margin has compressed sharply from the roughly 14% implied by FY2021 profit against FY2021 revenue, even as revenue itself has grown by 60% over the same five years.

The operating-leverage mechanism running through a group like this sits inside fixed manufacturing and engineering overhead at each subsidiary. Once a niche instrument maker's factory and technical staff are in place, incremental unit sales carry a disproportionate share of profit because the fixed cost base barely moves. That mechanism cuts in both directions: a slowdown in orders, such as the one that hit US research customers through 2024 and 2025, drops straight through to operating profit with limited offsetting cost flexibility in the near term. Management has also pointed to roughly a 10% drag on group operating profits from higher UK corporation tax and employer National Insurance, a cost pressure sitting outside any individual subsidiary's control.

Capital Allocation

Capital allocation follows a consistent order: fund organic capex and working capital across existing subsidiaries first, pay a dividend, then direct the remainder toward bolt-on acquisitions financed from operating cash flow and the revolving credit facility. The dividend yield stands at approximately 3.01% at current prices, consistent with a policy that has historically moved with profit rather than being fixed as a set payout ratio.

Acquisitions remain the core growth lever, though management flagged that dealmaking through 2025 was frustrated by cash-rich targets and sellers under no pressure to transact, a reminder that the buy-and-build model depends on finding businesses at disciplined multiples rather than simply having capital available. With £19.4 million of cash on hand and access to the revolving facility, the group appears to retain room to act should suitable targets appear, though the pace of future acquisitions may vary depending on what sellers are willing to accept.

Growth Outlook

Management's guidance for 2026 calls for Adjusted EPS in a range of 200p–250p. That range explicitly assumes the absence of a coring expedition until early 2027 and no recovery in US trading, a conservative pair of assumptions rather than a base case built on things going right.

Several catalysts sit behind that guidance range. A recovery in US federal research funding, should it materialize, could restore order flow that fell sharply through 2024 and 2025 amid funding cuts and freezes. Management's own guidance excludes this possibility entirely, meaning any improvement would represent upside to the stated range rather than a risk baked into it. A return of Geotek coring activity beyond the single Japan expedition booked in 2025 could add a further step-change to both revenue and profit, though the timing of any future expedition remains uncertain and management has pushed its own working assumption out to early 2027. Continued bolt-on acquisitions, contingent on finding targets at reasonable prices, would add both revenue and the operating leverage that comes from folding a new business into existing group infrastructure. Finally, the underlying replacement cycle for research instrumentation across university and government labs globally continues regardless of any single national budget cycle, providing a base of recurring demand beneath the more volatile pieces of the business.

Valuation Analysis

As of 22 September 2026, Judges Scientific shares trade at approximately £38.23, giving the group a market capitalization of roughly £252.8 million. The stock sits closer to its 52-week low of £34.80 than to its 52-week high of £67.00, a decline of more than 40% from the top of that range.

The trailing P/E of 46.6x looks rich set against a net margin of 4.1%, but it is distorted by the FY2025 impairment charge that depressed statutory earnings. The forward P/E of 18.9x, built on expectations for the year ahead, reads as more ordinary for a group growing revenue at high single digits with a history of double-digit operating margins. The dividend yield of approximately 3.01% adds a modest income component on top of any capital return.

Is it cheap? Not on trailing earnings, and not obviously so on forward earnings either, though the forward multiple sits well below the trailing one. The gap between the two is the entire valuation debate: pay 46.6x for a business that just wrote down part of its balance sheet, or 18.9x for the same business once that charge rolls off and US research funding either stabilizes or does not.

Competitive Landscape and Risks

Judges Scientific competes for research-lab budgets against both larger diversified acquirers and smaller specialists pursuing similar strategies. Halma plc, a much larger UK-listed acquirer of safety, health and instrumentation businesses, runs a broadly similar decentralized buy-and-build model at bigger deal sizes. Oxford Instruments plc makes high-technology scientific instruments spanning nanotechnology, cryogenics and imaging, overlapping with parts of the Vacuum segment's customer base. Spectris plc groups precision measurement and testing businesses competing for similar academic and industrial R&D spend. SDI Group plc, a smaller AIM-quoted peer, pursues a comparable acquisition strategy in adjacent niches, making it the closest structural comparison on the London market.

The key risks investors should monitor include:

1. US federal research-funding uncertainty. Orders from US customers fell sharply through 2024 and 2025 amid federal research-funding cuts and freezes. Management's 2026 Adjusted EPS guidance of 200p–250p explicitly assumes no recovery in US trading, underscoring how material this single market has become to near-term results.

1. Geotek coring-contract profit volatility. A meaningful share of group profit depends on the timing of Geotek's episodic, at most annual, coring expeditions. Their absence, as in 2024, or presence, as with the Japan expedition in 2025, can swing reported operating profit by a wide margin from one year to the next.

1. Acquisition execution and pricing risk. The growth strategy depends on sourcing and integrating further acquisitions at disciplined multiples. Management noted that 2025 dealmaking was frustrated by cash-rich targets and sellers who felt little pressure to transact, a dynamic that could persist and slow the pace of future deals.

1. Goodwill and intangible impairment. The group recognized a £4.3 million impairment to goodwill and acquired intangible assets in the FY2025 balance sheet, reflecting weaker trading at specific businesses. Further deterioration at any subsidiary could trigger additional write-downs.

1. Currency exposure. Roughly half of group revenue is priced in US Dollars and about a third in Euros, against a Sterling manufacturing cost base. Sustained Sterling strength would erode margins and export competitiveness across the portfolio.

Summary

The last five years show a group that keeps growing revenue even when the environment outside gets harder. Two decades of bolt-on acquisitions built a base of niche businesses that, individually, look unremarkable, but together span a wide enough set of research customers that no single funding cycle can sink the whole structure on its own. Revenue set a record in 2025, and the most recent half-year showed double-digit growth alongside a step-up in adjusted earnings per share.

The other side of the ledger is just as real. Profit has fallen in two of the last three years even as revenue climbed, squeezed by a goodwill impairment, a UK tax and National Insurance burden management estimates at roughly 10% of group operating profit, and a US funding freeze that 2026 guidance assumes will not lift. Net margin has fallen from roughly 14% five years ago to 4.1% today. The trailing P/E of 46.6x prices in a recovery that has not yet shown up in the reported numbers, while the forward multiple of 18.9x prices in one that management itself has stopped short of promising.

What ties the two views together is the structure itself: a holding company that has spent more than two decades finding businesses few investors have heard of, each dominant in its own narrow corner of scientific research, and adding them one at a time rather than betting the balance sheet on any single deal. The world's smallest monopolies do not always show up together on the same earnings line, but this one keeps finding new ones to add to the shelf.

Important disclaimer:

Data is taken from Fiscal.ai and company website.

The content provided in this newsletter is for informational purposes only and should not be construed as financial or investment advice. While I strive for accuracy, some metrics and data presented in these reports may not be entirely accurate or up-to-date. I take no responsibility for any investment decisions made based on the information provided herein.

Investing in the stock market, especially in undiscovered or lesser-known companies, carries inherent risks. The companies discussed in this newsletter may be subject to volatility, liquidity issues, and other factors that could impact their performance.

It is crucial that you conduct your own thorough research and due diligence before making any investment decisions. I strongly recommend consulting with a qualified financial advisor who can provide personalized advice based on your individual financial situation, risk tolerance, and investment goals.

Remember that past performance is not indicative of future results. The stock market is subject to fluctuations, and the value of investments may go up or down. You should only invest money that you can afford to lose.

By subscribing to and reading this newsletter, you acknowledge that you understand and accept these risks and limitations. You agree that I will not be held liable for any losses or damages resulting from the use of information provided in this newsletter.

Always invest responsibly and within your means. Your financial decisions are ultimately your own responsibility.

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

🇨🇦 CANADA — K-Bro Linen

K-Bro is the largest operator of laundry and linen plants in Canada, serving hospitals, hotels and businesses, and also operates in the UK.

Valued at about C$541M, trading at about 25x trailing P/E and 18x forward P/E, with revenue growing around 33% last quarter on the Stellar Mayan acquisition. Adjusted EBITDA margin slipped to about 20% from 21%, and net debt is near C$214M after the deal.

K-Bro Linen Inc. $KBL $KBL.TO

🇺🇸 UNITED STATES — CPI Card Group

CPI Card Group makes and personalizes debit, credit and prepaid payment cards for U.S. financial institutions, fintechs and prepaid programs, and sells instant-issuance software.

Valued at about $280M, trading at about 21x trailing P/E, with revenue up around 15% last quarter and free cash flow of about $36M in the first half against a management outlook of $45M to $50M for the year. Net leverage fell to 2.7x from 3.1x at year-end.

CPI Card Group Inc. $PMTS $PMTS.US

🇦🇺 AUSTRALIA — PWR Holdings

PWR designs and makes aluminium cooling products for motorsport teams, aerospace and defence programs, and automotive makers.

Valued at about A$1.2B, growing revenue by around 31% and net profit by about 83%, with a net margin of roughly 10.5% and motorsport making up close to 60% of sales. Net debt is only about A$6M and the dividend yield is around 0.7%.

PWR Holdings Limited $PWH $PWH.AX

🇦🇪 UNITED ARAB EMIRATES — National Central Cooling Company

Tabreed runs district cooling plants that supply chilled water to homes, offices and industrial sites, mainly in the UAE.

Valued at about AED 7B, trading at about 18x trailing P/E, 14x forward P/E, 12x EV/EBITDA and 5x EV/revenue, with a 5%+ dividend yield. First-half revenue grew about 2% on a 55% EBITDA margin, though EBITDA dipped 2% and net debt to EBITDA is about 4.6x.

National Central Cooling Company PJSC $TABREED $TABREED.AE

🔥 Looking for detailed research analyses of undiscovered companies around the world, top monthly discoveries, and a list of 100+ undiscovered stocks from around the globe? Become a Paid Subscriber and get many more benefits!

Disclaimer: This analysis is provided for informational and educational purposes and should not be construed as financial advice or a recommendation to buy or sell any security. The data and information presented have been obtained from sources believed to be reliable, but their accuracy and completeness cannot be guaranteed. Any investment decision should be made based on your own research, risk tolerance and financial situation. Stock markets and investments carry significant risks, possible loss of principal, and past performance does not guarantee future results. The author may hold positions in the securities discussed. The opinions expressed here reflect our best analysis at this point in time, but views and circumstances change rapidly. Always conduct thorough due diligence and consult with a qualified financial advisor before making any investment decisions. The analysis presented here may become outdated quickly due to the dynamic nature of markets and businesses. You are responsible for your own investment decisions, and should understand the risks of any investment before committing capital.

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

In 1992, a small excavation contractor in Alberta started testing a different way to dig. Pressurized water loosened the soil instead of a steel bucket. A vacuum system pulled the loosened dirt away in seconds, leaving a clean hole and the gas line, fiber cable or water main underneath it untouched. It looked like a novelty. It became a business built on preventing the exact kind of accident that makes the evening news, a mechanical excavator tearing through a live utility line.

Three decades later, that contractor runs roughly 140 field locations across Canada and the United States, builds its own trucks in a plant with room to produce more than 350 of them a year, and collects a fee every time a crew shows up to expose buried infrastructure before anyone digs blind. Revenue has grown every year since 2021, most recently past $800 million. The process it commercialized still carries no patent. The stock trades at more than 30 times trailing earnings anyway.

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

Imagine a drug company that is, by design, forbidden from mass-producing its own medicine. No factory line churning out identical tablets by the million, no single blockbuster brand carrying the income statement. Instead, this company's entire reason for existing is to make medicine that nobody else will make, in doses nobody else will make it in, for patients that the standard industrial pharmaceutical supply chain simply cannot serve. A child who needs one-tenth of an adult dose in liquid form. A hospital facing a shortage of an essential injectable. A patient allergic to the dye in an otherwise perfectly good generic pill.

This is the business of pharmaceutical compounding, and one company has spent more than three decades quietly assembling a global infrastructure around it, supplying raw ingredients, running its own compounding facilities, and even operating FDA-registered outsourcing plants that manufacture sterile, personalized drugs at hospital scale. Revenue has compounded (the pun, in this case, is unavoidable) from under €600 million to nearly a billion euros in just four years. And yet almost nobody outside of specialist healthcare investing circles has ever heard its name. The valuation tension is real too, sell-side analysts are notably bullish, but a recent regulatory letter from the FDA has added a fresh wrinkle to the story just as the market was getting comfortable with it.

Read more

Look…

Read more

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

🇸🇪 SWEDEN — Bufab

Bufab is a Swedish trading company that sources, quality-checks and warehouses industrial fasteners and other small "C-parts" so manufacturers do not have to run that supply chain themselves, operating through 50-plus companies across roughly 28 to 31 countries.

Q2 FY2026 net sales grew about 11%, around 5% organic, with operating margin near 14.7% and gross margin around 33.2%. Full-year 2025 operating margin was about 13.3% against a 14% management target for 2026, and analyst consensus rates it Outperform with an average consensus price target of SEK 135.

Bufab AB (publ) $BUFAB $BUFAB.ST

🇳🇱 NETHERLANDS — Kendrion

Kendrion makes electromagnetic actuators, solenoids, industrial brakes and clutches, and control electronics for machine motion and safety, serving robotics, automation, medical technology and energy customers after a 2025 shift toward a pure-play industrial motion-control model.

H1 2026 revenue rose about 4%, with normalized EBITDA margin near 17.5%, at the top of its 15-18% target range. FY2025 operating margin was about 8.7% and net margin about 7.9%, management is targeting a dividend of at least 50% of normalized net profit, and consensus rates it Buy with an average consensus price target of EUR 22.

Kendrion N.V. $KENDR $KENDR.AS

🇦🇺 AUSTRALIA — Objective Corporation

Objective Corporation is an Australian GovTech software company supplying enterprise content and records management, regulatory compliance workflow, and e-planning software mostly to government and regulated-industry customers across Australia, New Zealand, the UK and North America.

Subscription made up about 84% of FY2025 revenue and reached 100% of software revenue by FY2026, with adjusted EBITDA margin near 39% and net cash on the balance sheet. After losing its roughly 25-year Australian Department of Defence contract, FY2027 guidance implies a sharp earnings step-down and shares fell about 18% on results day, though consensus still rates it Buy, with analyst price targets now ranging widely, roughly A$12.51 to A$22.43.

Objective Corporation Limited $OCL $OCL.AX

🇨🇦 CANADA — Savaria

Savaria designs, manufactures and installs accessibility and patient-handling equipment, from home and commercial elevators and stairlifts to wheelchair-accessible vehicle conversions and medical beds, selling through about 1,500 dealers and 28 direct sales offices worldwide.

Q2 FY2026 revenue grew about 8.4%, around 6.6% organic, with net earnings up roughly 54% and operating margin expanding to about 14.6% from 11.8%. Management's 2030 targets call for around 12% annual revenue growth and an adjusted EBITDA margin near 20%, and analyst consensus rates it Buy with an average consensus price target near C$34 to C$36.

Savaria Corporation $SIS $SIS.TO

🔥 Looking for detailed research analyses of undiscovered companies around the world, top monthly discoveries, and a list of 100+ undiscovered stocks from around the globe? Become a Paid Subscriber and get many more benefits!

Disclaimer: This analysis is provided for informational and educational purposes and should not be construed as financial advice or a recommendation to buy or sell any security. The data and information presented have been obtained from sources believed to be reliable, but their accuracy and completeness cannot be guaranteed. Any investment decision should be made based on your own research, risk tolerance and financial situation. Stock markets and investments carry significant risks, possible loss of principal, and past performance does not guarantee future results. The author may hold positions in the securities discussed. The opinions expressed here reflect our best analysis at this point in time, but views and circumstances change rapidly. Always conduct thorough due diligence and consult with a qualified financial advisor before making any investment decisions. The analysis presented here may become outdated quickly due to the dynamic nature of markets and businesses. You are responsible for your own investment decisions, and should understand the risks of any investment before committing capital.

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

Imagine a company that, for fifteen years running, never once posted a year of shrinking revenue. Not through the aftershocks of the 2008 financial crisis. Not through a global pandemic that shut down factories across three continents. Not through the tariff shocks and supply-chain scrambles of the years that followed. It just kept growing, quietly, without ever landing on a hot-stock screener or in a headline anyone outside its own industry would recognize. Then, in 2026, its chairman stood in front of investors and admitted the streak was over.

The business behind that streak does not sell anything you would recognize by name. It sells the parts that let other things work: the cable assembly that carries current from a solar panel to an inverter, the connector buried inside a hospital patient monitor, the sensor threaded through an EV charging gun, the wiring harness inside an industrial robot arm. It groups the five industries it serves under a five-letter acronym that reads, depending on who you ask, like either a supervillain's masterplan or a marketing department's fever dream. What happens to a thirty-seven-year-old compounder when one of its five pillars falls over in the same year Wall Street starts pricing in an AI-driven rebound? And what happens to a stock whose bulls are still betting the streak resumes?

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

Imagine a Friday night out at the movies. You pick a film on an app, choose your seat from a digital map, tap through a self-service kiosk to grab your ticket, and settle in as the trailers roll. Somewhere behind every one of those steps, in cinemas across more than 90 countries, the same piece of software is quietly doing the work — scheduling showtimes, processing the transaction, feeding the box-office numbers back to a studio, and building a marketing profile the exhibitor will use to sell you popcorn and a loyalty membership next time. You have almost certainly used this company's technology. You have almost certainly never heard its name.

For years, that ubiquity did not translate into a business that made money. The company built a global footprint by licensing software to exhibitors and distributors, weathered a pandemic that emptied theaters worldwide, and then spent several more years bleeding cash as it rebuilt around a subscription model. Losses piled up, year after year, even as revenue kept climbing. Then, quietly, the losses stopped. A small profit appeared. Guidance for the following year was raised. And the company took on its first meaningful debt in years to fund the final stretch of that transition. The question now is whether a business this deeply embedded in an industry investors rarely think about is finally worth their attention — or whether the fresh debt load is a warning sign dressed up as a growth story.

Read more

Ready to discover the world of public, yet truly undiscovered companies? Subscribe now!

🎧 Want to explore more company insights? I'm now releasing free audio overviews — separate from the paid deep dives — designed as engaging, conversational breakdowns of different businesses. It's a great way to discover new ideas on the go.

Teaser

Imagine a company that sells almost nothing you could recognize on a store shelf, because its products only make sense several hundred meters underwater. It builds sensors sharp enough to map the seafloor in resolutions fine enough to pick out debris the size of a shoebox, batteries dense enough to keep unmanned submersibles running for days, and it quietly rents out entire fleets of survey and inspection equipment to navies and offshore energy operators who would rather lease the capability than own it outright.

For most of two decades, this business built itself in relative obscurity, growing revenue roughly fourfold in just four years while barely registering in mainstream financial coverage. Then, in the summer of 2026, it did something audacious. It went out and bought a business several times its own size, absorbing five well-known names in underwater acoustics and navigation in a single transaction. Overnight, a company almost nobody had heard of roughly tripled in scale, and the market is still working out what that is worth.

Read more